HP Inc. is deploying its longstanding inkjet printer technology in a novel way to more easily and accurately dispense tiny amounts of drug candidates or treatments into patient samples for testing. It's currently working with a number of pharmaceutical companies, as well as academic and research labs, with this technology. Read More
NEW DELHI – India's vaccine industry is limping to recovery after a number of setbacks in growth in recent months even as some industry experts worry that the domestic sector is losing ground to China and South Korea. Read More
By simultaneously targeting two opioid receptor subtypes, researchers from Wake Forest School of Medicine and Astraea Therapeutics Inc. have developed a compound that, in nonhuman primates, was an effective analgesic that not only lacked the rewarding effects of currently used opioid analgesic, but blocked those effects, making it a potential treatment for both pain and opioid addiction. Read More
With a trade war hanging in the air over two national capitals, Sen. Marco Rubio (R-Fla.) has introduced a bill that would ratchet up the pressure on Beijing regarding products included in the Made in China 2025 program. The new bill, dubbed the Fair Trade with China Enforcement Act of 2018, would impose restrictions on China's ability to invest in companies across a range of industries, including biologics and "advanced medical equipment," and would prohibit the export to China of any intellectual property (IP) for artificial intelligence and biotechnology, thus applying further pressure on Beijing to tamp down on what many people believe is the nation's rampant intellectual property theft. Read More
Shire plc, of Dublin, completed the sale of its oncology franchise to Servier S.A.S. for $2.4 billion. David Lee, who was previously the head of Shire's Global Genetic Diseases and Oncology franchises, will continue with Servier as CEO of its new U.S. commercial subsidiary, Servier Pharmaceuticals. Read More
Scientists at Stanford University have shown that activation of the opioid transmission system was necessary for ketamine's antidepressant effects. Ketamine, originally developed for its anesthetic properties, is also an effective antidepressant in about half of all individuals with treatment-resistant depression. Read More
LONDON – Evox Therapeutics Ltd. is now funded to advance its engineered exosomes into clinical development, after closing an oversubscribed £35.5 million (US$46.1 million) series B round. Read More
